Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Shares Issued (2017 - 2022)

Nephros (NEPH) has 12 years of Shares Issued data on record, last reported at $163000.0 in Q1 2022.

  • For Q1 2022, Shares Issued rose 162.9% year-over-year to $163000.0; the TTM value through Dec 2022 reached $163000.0, down 20.1%, while the annual FY2022 figure was $163000.0, 20.1% down from the prior year.
  • Shares Issued reached $163000.0 in Q1 2022 per NEPH's latest filing, up from -$93000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $6.8 million in Q1 2020 and bottomed at -$6.6 million in Q4 2020.
  • Average Shares Issued over 5 years is -$17454.5, with a median of $138000.0 recorded in 2018.
  • Peak YoY movement for Shares Issued: skyrocketed 1825.0% in 2018, then tumbled 1756.3% in 2019.
  • A 5-year view of Shares Issued shows it stood at $119000.0 in 2018, then crashed by 1756.3% to -$2.0 million in 2019, then plummeted by 235.26% to -$6.6 million in 2020, then skyrocketed by 98.59% to -$93000.0 in 2021, then surged by 275.27% to $163000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $163000.0 in Q1 2022, -$93000.0 in Q4 2021, and $235000.0 in Q2 2021.